ArticleJournal of thrombosis and thrombolysis2018

A direct oral factor Xa inhibitor edoxaban ameliorates neointimal hyperplasia following vascular injury and thrombosis in apolipoprotein E-deficient mice.

Yoshiyuki Morishima et al.PubMed ↗Publisher ↗

No numbers read from the abstract.